Alembic Pharmaceuticals Limited (APLLTD.NS)

INR 1045.0

(-1.06%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 64.45 Billion 61.82 Billion 71.22 Billion 67.08 Billion 59.89 Billion 47.77 Billion
Total Current Assets 30.78 Billion 29.1 Billion 28.6 Billion 25.77 Billion 24.62 Billion 19.57 Billion
Cash And Short Term Investments 1.26 Billion 921.2 Million 610.9 Million 2.85 Billion 718.4 Million 1.99 Billion
Cash and Cash Equivalents 1.26 Billion 754.8 Million 610.9 Million 980.6 Million 718.4 Million 1.99 Billion
Short Term Investments 271.3 Million 166.4 Million 316.2 Million 1.86 Billion - -
Net Receivables 10.24 Billion 11.29 Billion 11.9 Billion 8.06 Billion 12.03 Billion 6.15 Billion
Inventory 16.43 Billion 14.75 Billion 16.09 Billion 14.86 Billion 11.87 Billion 9.67 Billion
Other Current Assets 2.83 Billion 2.13 Billion -100 Thousand -100 Thousand 200 Thousand 1.76 Billion
Total Non-Current Assets 33.67 Billion 32.72 Billion 42.61 Billion 41.31 Billion 35.26 Billion 28.2 Billion
Net PPE 30.71 Billion 29.99 Billion 39.47 Billion 36.48 Billion 30.99 Billion 24.39 Billion
Good Will And Intangible Assets -100 Thousand - 1.54 Billion 3.22 Billion 2.99 Billion 2.69 Billion
Good Will - - - - - 36 Million
Intangible Assets - - 1.54 Billion 3.22 Billion 2.99 Billion 2.66 Billion
Long-Term Investments 930.2 Million 963.3 Million 1.18 Billion 493.1 Million 176.2 Million 487.6 Million
Tax Assets 1.69 Billion 1.23 Billion 58.8 Million 1.1 Billion 1.1 Billion 148.5 Million
Other Non Current Assets 333 Million 537.4 Million 348.8 Million -100 Thousand -100 Thousand 467.3 Million
Other Assets - - - - - -1.7 Million
Total Liabilities 16.27 Billion 18.12 Billion 18.84 Billion 16.42 Billion 27.98 Billion 20.59 Billion
Total Current Liabilities 14.54 Billion 16.36 Billion 17.16 Billion 12.8 Billion 17.51 Billion 14.89 Billion
Account Payables 7.35 Billion 6.79 Billion 7.06 Billion 6.68 Billion 6.25 Billion 50.9 Million
Tax Payables - - - 21.5 Million - 36.1 Million
Short Term Debt 4.5 Billion 6.52 Billion 6.44 Billion 3.12 Billion 8.7 Billion 6.29 Billion
Deferred Revenue 157.6 Million 2.18 Billion 3.65 Billion 2.99 Billion 2.13 Billion 8.34 Billion
Other Current Liabilities 2.53 Billion 855.4 Million -100 Thousand 200 Thousand 418.9 Million 213.5 Million
Total Non Current Liabilities 1.72 Billion 1.75 Billion 1.67 Billion 3.61 Billion 10.47 Billion 5.7 Billion
Long-Term Debt 628.8 Million 692.3 Million 721.4 Million 2.71 Billion 9.6 Billion 4.99 Billion
Deferred Revenue Non Current -1.31 Billion -831.4 Million -1.97 Billion 855.2 Million 745.1 Million 520.3 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.09 Billion 1.06 Billion 958.1 Million 100 Thousand 100 Thousand 200 Thousand
Other Liabilities 1.00 - - - - -
Total Equity 48.18 Billion 43.7 Billion 52.37 Billion 50.66 Billion 31.9 Billion 27.18 Billion
Stock Holders Equity 48.18 Billion 43.7 Billion 52.37 Billion 51.27 Billion 32.19 Billion 27.18 Billion
Common Stock 393.1 Million 393.1 Million 393.1 Million 393.1 Million 377 Million 377 Million
Retained Earnings 40.27 Billion 35.68 Billion 25.54 Billion 24.24 Billion 15.38 Billion 12.86 Billion
Accumulated other comprehensive income 47.78 Billion 335.4 Million 18.8 Billion 18.51 Billion -4.95 Billion -3.51 Billion
Common Stock Equity 48.18 Billion 43.7 Billion 52.37 Billion 51.27 Billion 32.19 Billion 27.18 Billion
Capital Lease Obligation 628.8 Million 861.5 Million 871.2 Million 838.2 Million 832 Million -
Total Investments 930.2 Million 963.3 Million 1.18 Billion 493.1 Million 176.2 Million 487.6 Million
Total Debt 5.13 Billion 7.22 Billion 7.17 Billion 5.83 Billion 18.3 Billion 11.28 Billion
Net Debt 3.86 Billion 6.46 Billion 6.56 Billion 4.85 Billion 17.58 Billion 9.29 Billion

Balance Sheet Charts